[2021] Flow Cytometry Market Revenue Opportunies With Top Players - Becton Dickinson and Company, General Electric Company, Luminex Corporation

Flow cytometry is a laser-based biophysical technology employed in protein engineering, biomarker detection, cell sorting, and cell counting. It is required to a conduct study related to the blood. Flow cytometry analyzes the chemical and physical characteristics of the particles present in the blood. It is used to diagnose health disorders such as HIV and cancer along with several applications in basic research, clinical trials, and clinical practice. Flow cytometry is widely used for evaluating peripheral blood, bone marrow, and other body fluids. Moreover, it provides rapid analysis of multiple characteristics of single cells. The process finds application in microbiology, immunology, hematology, cytology, and among other research fields.

This Research Help Grow Your Business @ https://www.coherentmarketinsights.com/insight/request-sample/1152

The increasing prevalence of chronic diseases worldwide and the need for rapid, accurate, and sensitive prognosis techniques for disease validation are expected to propel the growth of the flow cytometry market. According to the World Health Organization (WHO), chronic diseases are the leading cause of death worldwide. Moreover, increasing technological advancements (as flow cytometry is quite an unexplored field) and the introduction of advanced methods such as improved cell sorting, higher resolution, rapid detection, and multifunctional analysis, ensuring enhanced efficiency in identifying and characterizing novel drugs are also expected to augment the market growth.

The key Flow Cytometry industry leaders profiled in the report include Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc. and Danaher Corporation.. These key players have adopted strategies, such as product portfolio expansion, mergers & acquisitions, agreements, geographical expansion, and collaborations, to enhance their market penetration

For instance, in 2017, the United States Food Drug and Administration (FDA) approved the use of a flow cytometer in the detection of lymphoma and leukemia cancer (blood cancer). In 2019, about 76,200 Americans were expected to be diagnosed with myeloma, lymphoma, or leukemia cancer, according to the Leukemia and Lymphoma Society. Moreover, in 2020, around 60,530 people are expected to be diagnosed with leukemia. Furthermore, the growing prevalence of cancer and HIV are expected to foster the flow cytometry market growth.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report : https://www.coherentmarketinsights.com/promo/buynow/1152

Flow Cytometry Market Segmentation

Based on type, the absolute Flow Cytometrys segment contributed to the largest share in 2020, accounting for more than two-fifths of the total share, and is estimated to maintain its dominant position during the forecast period.

By Technology:
Cell-Based
Bead-Based

By Product Type:
Analyzer
Sorter
Reagents & Consumables

By Application:
Research
Clinical
Industrial

By End User:
Hospital
Clinical Testing Laboratories
Research laboratories

Get Sample PDF Brochure@ https://www.coherentmarketinsights.com/insight/request-pdf/1152

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights' market intelligence service provides a comprehensive view of the market, using the existing sources of information. Our market intelligence service addresses key challenges of a market; helps in finding opportunities across various industries, and helps potential investors and partners to support the strategic decision-making process.

This release was published on openPR.